Regencell Bioscience Holdings Ltd
Research Regencell Bioscience Holdings Ltd (RGC) on Bullrun: market cap USD 3.06B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRGC
- ExchangeNASDAQ
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 3.06B
- Financial periodFY2025
- Net income-USD 3.58M
- Free cash flow-USD 3.27M
Valuation Snapshot
latest market cap is USD 3.06B.
About Regencell Bioscience Holdings Ltd
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Frequently asked questions
What is Regencell Bioscience Holdings Ltd's market cap?
Regencell Bioscience Holdings Ltd's market capitalization is USD 3.06B.
What does Regencell Bioscience Holdings Ltd do?
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity...